Postdoctoral Research Associate

Employment Type
Regular Full-Time
Requisition number
1924
Department
Khor Lab
Location : City
Seattle

Overview

The Khor laboratory is a high-mentoring environment currently seeking a highly motivated and creative individual for the position of Postdoctoral Research Associate. The scientist will be engaged in studying novel pathways regulating inflammation, autoimmunity and aging particularly in the context of Down syndrome. Work includes both human and animal models and is highly collaborative and cross-disciplinary. Immunology, in vivo mouse model and systems biology experience is highly desirable.  Our goal is to empower precision therapy of immune-medicated diseases in people with and without down syndrome.

Responsibilities

The successful candidate will be expected to design and implement projects, work with both human samples and mice, collaborate within and between labs, participate in the drafting of scientific publications and funding proposals, and may, with direction from the PI, supervise technical support personnel. This is a transitory training position; the selected individual will receive strong mentoring to promote scientific growth and development.

Qualifications

  • Recent or anticipated PhD, MD or MD/PhD
  • Excellent written and oral communication skills
  • Collaborative; performs as team member and has good interpersonal skills
  • Strong analytical and organizational skills with excellent attention to detail
  • Ability to work independently and effectively
  • Proven track record of problem-solving
  • Publication in peer-reviewed journals

Compensation

$67,744 - $77,488 per year; depending on years of postdoctoral experience.

Benefits

  • Medical, dental, vision hardware insurance
  • Flexible spending accounts: health care, dependent care, commuter
  • Short and long-term disability and life and AD&D insurance
  • 403(b) retirement plan with matching funds after one year of employment
  • PTO: 13 holidays, three weeks of vacation and two weeks of sick leave per year
  • Employee assistance program
  • Educational assistance program
  • Subsidized bus pass
  • YMCA rebate and other fitness club discounts
  • Voluntary benefits, e.g., pet insurance, accident, critical illness, identify theft
  • See benaroyaresearch.org for benefit details 

About Us

Benaroya Research Institute (BRI) has a bold mission: To predict, prevent, reverse and cure immune system diseases, from autoimmune disease to cancer to COVID-19. We examine the immune system in both health and disease to understand how disorders start and how to rebalance the immune system back to health. Equipped with innovative tools and robust biorepositories, our team chips away at the biggest mysteries behind these conditions to work toward our vision of a healthy immune system for everyone. BRI is a world-renowned independent nonprofit research institute affiliated with Virginia Mason Franciscan Health and based in Seattle. We collaborate with clinicians to accelerate the path from innovative lab discoveries to life-changing patient care.

 

At BRI, each role is valued and an important contributor to our vision and mission. BRI is committed to a safe, caring and diverse workplace; as well as to taking action to further our commitment to foster inclusion, equity and belonging so employees feel comfortable bringing their full selves to work. Consider making a difference by joining our team. Because together, we are powering possibility.

 

To learn more, visit benaroyaresearch.org and connect with us on Facebook, Instagram, Threads,  LinkedIn, X and YouTube.

 

 

All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status.

 

If you need assistance completing the application process, please contact Human Resources at 206-342-6972 or email jobs@benaroyaresearch.org.

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed